TY - JOUR
T1 - Case Report
T2 - Rare Homozygous RNASEH1 Mutations Associated With Adult-Onset Mitochondrial Encephalomyopathy and Multiple Mitochondrial DNA Deletions
AU - Manini, Arianna
AU - Caporali, Leonardo
AU - Meneri, Megi
AU - Zanotti, Simona
AU - Piga, Daniela
AU - Arena, Ignazio Giuseppe
AU - Corti, Stefania
AU - Toscano, Antonio
AU - Comi, Giacomo Pietro
AU - Musumeci, Olimpia
AU - Carelli, Valerio
AU - Ronchi, Dario
N1 - Funding Information:
This work was partially supported by the Italian Ministry of Health (Ministero della Salute), Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico Grant Ricerca Corrente 2020 to GPC, and IRCCS Istituto delle Scienze Neurologiche di Bologna Grant Ricerca Corrente 2020 to LC and VC. This work was promoted within the European Reference Network (ERN) for Neuromuscular Diseases.
Publisher Copyright:
Copyright © 2022 Manini, Caporali, Meneri, Zanotti, Piga, Arena, Corti, Toscano, Comi, Musumeci, Carelli and Ronchi.
PY - 2022/5/31
Y1 - 2022/5/31
N2 - Mitochondrial DNA (mtDNA) maintenance disorders embrace a broad range of clinical syndromes distinguished by the evidence of mtDNA depletion and/or deletions in affected tissues. Among the nuclear genes associated with mtDNA maintenance disorders, RNASEH1 mutations produce a homogeneous phenotype, with progressive external ophthalmoplegia (PEO), ptosis, limb weakness, cerebellar ataxia, and dysphagia. The encoded enzyme, ribonuclease H1, is involved in mtDNA replication, whose impairment leads to an increase in replication intermediates resulting from mtDNA replication slowdown. Here, we describe two unrelated Italian probands (Patient 1 and Patient 2) affected by chronic PEO, ptosis, and muscle weakness. Cerebellar features and severe dysphagia requiring enteral feeding were observed in one patient. In both cases, muscle biopsy revealed diffuse mitochondrial abnormalities and multiple mtDNA deletions. A targeted next-generation sequencing analysis revealed the homozygous RNASEH1 mutations c.129-3C>G and c.424G>A in patients 1 and 2, respectively. The c.129-3C>G substitution has never been described as disease-related and resulted in the loss of exon 2 in Patient 1 muscle RNASEH1 transcript. Overall, we recommend implementing the use of high-throughput sequencing approaches in the clinical setting to reach genetic diagnosis in case of suspected presentations with impaired mtDNA homeostasis.
AB - Mitochondrial DNA (mtDNA) maintenance disorders embrace a broad range of clinical syndromes distinguished by the evidence of mtDNA depletion and/or deletions in affected tissues. Among the nuclear genes associated with mtDNA maintenance disorders, RNASEH1 mutations produce a homogeneous phenotype, with progressive external ophthalmoplegia (PEO), ptosis, limb weakness, cerebellar ataxia, and dysphagia. The encoded enzyme, ribonuclease H1, is involved in mtDNA replication, whose impairment leads to an increase in replication intermediates resulting from mtDNA replication slowdown. Here, we describe two unrelated Italian probands (Patient 1 and Patient 2) affected by chronic PEO, ptosis, and muscle weakness. Cerebellar features and severe dysphagia requiring enteral feeding were observed in one patient. In both cases, muscle biopsy revealed diffuse mitochondrial abnormalities and multiple mtDNA deletions. A targeted next-generation sequencing analysis revealed the homozygous RNASEH1 mutations c.129-3C>G and c.424G>A in patients 1 and 2, respectively. The c.129-3C>G substitution has never been described as disease-related and resulted in the loss of exon 2 in Patient 1 muscle RNASEH1 transcript. Overall, we recommend implementing the use of high-throughput sequencing approaches in the clinical setting to reach genetic diagnosis in case of suspected presentations with impaired mtDNA homeostasis.
KW - CPEO
KW - RNASEH1
KW - mitochondrial DNA
KW - mtDNA maintenance disorders
KW - myopathy
KW - ribonuclease H1
UR - https://www.scopus.com/pages/publications/85132450056
U2 - 10.3389/fgene.2022.906667
DO - 10.3389/fgene.2022.906667
M3 - Article
C2 - 35711919
SN - 1664-8021
VL - 13
JO - Frontiers in genetics
JF - Frontiers in genetics
M1 - 906667
ER -